The treatment of tetanus with special reference to betamethasone.
D000328:Adult; D001623:Betamethasone / Q000008:administration & dosage* / Q000009:adverse effects / Q000494:pharmacology; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D005260:Female; D006470:Hemorrhage / Q000139:chemically induced; D006633:Histamine Antagonists; D006801:Humans; D007223:Infant; D007273:Injections, Intramuscular; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D010277:Parasympathomimetics / Q000037:antagonists & inhibitors; D011395:Promazine / Q000627:therapeutic use; D013742:Tetanus / Q000188:drug therapy* / Q000401:mortality; D013743:Tetanus Antitoxin / Q000008:administration & dosage; D013744:Tetanus Toxin / Q000037:antagonists & inhibitors
D006633:Histamine Antagonists; D010277:Parasympathomimetics; D013743:Tetanus Antitoxin; D013744:Tetanus Toxin; D001623:Betamethasone; D011395:Promazine